Pathophysiology of itching [3]

Lancet

Volumn 349, Issue 9045, 1997, Pages 133-

  Greaves, M W ^a   Wall, P D ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; OPIATE AGONIST; OPIATE RECEPTOR;

CONTROLLED STUDY; HUMAN; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; NOTE; PHYSIOLOGY;

HUMANS; PRURITUS; RECEPTORS, OPIOID;

EID: 0031564431     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60916-6     Document Type: Letter

References (5)

1. JD Bernhard Pathophysiology of itching Lancet 348 1996 1513 1514
2. MW Greaves PD Wall Pathophysiology of itching Lancet 348 1996 938 940
3. L Krause S Shuster Mechanism of action of antipruritic drugs BMJ 287 1983 1199 1200
4. V Doherty DGH Sylvester CTC Kennedy Double blind trial of acrivastine, terfenadine or placebo in 49 patients with atopic dermatitis showed improvements with both but no difference between the active agents BMJ 298 1989 96
5. HA Sampson KR Broadbent J Bernhisel-Broadbent Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity N Engl J Med 321 1989 228 232